Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells.

Standard

Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells. / Riddell, Stanley R; Berger, Susanna Carolina; Jensen, Michael C.

Patent Nr.: US10,400,215B2.

Publikationen: PatentPatentschriften und andere Schutzrechte

Harvard

APA

Riddell, S. R., Berger, S. C., & Jensen, M. C. (2014). Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells. (Patent Nr. US10,400,215B2).

Vancouver

Bibtex

@misc{8457d3fd651a4951ac3b584410283955,
title = "Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells.",
abstract = "The present invention provides a method of carrying out adoptive immunotherapy in a primate subject in need thereof by administering the subject a cytotoxic T lymphocytes (CTL) preparation in a treatment-effective amount. The method comprises administering as the CTL preparation a preparation consisting essentially of an in vitro expanded primate CTL population, the CTL population enriched prior to expansion for central memory T lymphocytes, and depleted prior to expansion of effector memory T lymphocytes. In some embodiments, the method may further comprise concurrently administering Interleukin-15 to the subject in an amount effective to increase the proliferation of the central memory T cells in the subject. Pharmaceutical formulations produced by the method, and methods of using the same, are also described.",
author = "Riddell, {Stanley R} and Berger, {Susanna Carolina} and Jensen, {Michael C}",
year = "2014",
language = "English",
type = "Patent",
note = "US10,400,215B2; C12N 5/0638",

}

RIS

TY - PAT

T1 - Adoptive Transfer of CD8+ T Cell Clones Derived from Central Memory Cells.

AU - Riddell, Stanley R

AU - Berger, Susanna Carolina

AU - Jensen, Michael C

PY - 2014

Y1 - 2014

N2 - The present invention provides a method of carrying out adoptive immunotherapy in a primate subject in need thereof by administering the subject a cytotoxic T lymphocytes (CTL) preparation in a treatment-effective amount. The method comprises administering as the CTL preparation a preparation consisting essentially of an in vitro expanded primate CTL population, the CTL population enriched prior to expansion for central memory T lymphocytes, and depleted prior to expansion of effector memory T lymphocytes. In some embodiments, the method may further comprise concurrently administering Interleukin-15 to the subject in an amount effective to increase the proliferation of the central memory T cells in the subject. Pharmaceutical formulations produced by the method, and methods of using the same, are also described.

AB - The present invention provides a method of carrying out adoptive immunotherapy in a primate subject in need thereof by administering the subject a cytotoxic T lymphocytes (CTL) preparation in a treatment-effective amount. The method comprises administering as the CTL preparation a preparation consisting essentially of an in vitro expanded primate CTL population, the CTL population enriched prior to expansion for central memory T lymphocytes, and depleted prior to expansion of effector memory T lymphocytes. In some embodiments, the method may further comprise concurrently administering Interleukin-15 to the subject in an amount effective to increase the proliferation of the central memory T cells in the subject. Pharmaceutical formulations produced by the method, and methods of using the same, are also described.

M3 - Patent

M1 - US10,400,215B2

Y2 - 2014/06/12

ER -